Results 61 to 70 of about 21,752 (228)
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
Epidermolysis Bullosa is a group of inherited dermatological disorder with severe clinical symptoms. Children and adolescents with epidermolysis bullosa have been reported to experience psychosocial problems in addition to the symptoms associated with ...
Ozalp Ekinci +3 more
doaj
Periodontitis and Periodontal Conditions in Systemically Healthy Children and Adolescents
ABSTRACT Objective To answer the PICoS question ‘in systemically healthy children and adolescents (Population), what are the main features of periodontitis, necrotising periodontal diseases (NPD) and other periodontal conditions (periodontal abscesses, endo‐periodontal lesions, traumatic occlusal forces, prosthesis‐ and tooth‐related factors ...
Inbar Eshkol‐Yogev +5 more
wiley +1 more source
Pyloric atresia-Three cases and review of literature
Pyloric atresia (PA) is a rare congenital anomaly that constitutes approximately 1% of all intestinal atresias, and its incidence is approximately 1 in 100,000 live births. PA may occur as an isolated condition or associated with other abnormalities, the
Sandesh V Parelkar +6 more
doaj +1 more source
Una mariposa diferente. Cuidados al niño con epidermólisis bullosa [PDF]
Trabajo fin de grado en EnfermeríaIntroducción La Epidermólisis Bullosa, comúnmente conocida como la "enfermedad de la piel de mariposa", es una de las miles de enfermedades raras.
Perez Cruz, Sara
core
Expanded carrier screening: A current perspective [PDF]
Prenatal carrier screening has expanded to include a large number of genes offered to all couples considering pregnancy or with an ongoing pregnancy.
Al-Kouatly, Hb +12 more
core +1 more source
European S2k guidelines on management of autoimmune blistering diseases in children and adolescents
Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda +31 more
wiley +1 more source
Atención enfermera al paciente pediátrico con epidermolisis bullosa. Revisión bibliográfica [PDF]
INTRODUCCIÓN. La epdiermólisis bullosa (EB) es una enfermedad de baja prevalencia, perteneciente a las genodermatosis de etiología genética, que se caracteriza por la deficiencia parcial o total de alguna de las proteínas que conforman los estratos ...
Blanco Asensio, Elena
core
Skin Fragility and Hyperpigmentation in a Patient With HIV
JEADV Clinical Practice, EarlyView.
Catalina Retamal +2 more
wiley +1 more source
Incidence of P200 pemphigoid: A nationwide study
The anti‐LAMB4 cell‐based immunoassay is a new serological technique that is far superior to dermal immunoblotting for detecting autoantibodies directed against the P200 protein. This method allows a re‐evaluation of the incidence of P200 pemphigoid, which appears to be considerably more frequent than epidermolysis bullosa acquisita.
Fabienne Jouen +7 more
wiley +1 more source

